CYP 3.85% 25.0¢ cynata therapeutics limited

Ann: Investor Presentation, page-425

  1. 832 Posts.
    lightbulb Created with Sketch. 338
    Yup, it certainly is impossible to sell once you realise how undervalued this is relative to other MSC companies, let alone the step-change improvement offered by iPSC derived MSCs.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.